Back to Search Start Over

Elsberg syndrome following acute immunosuppressive treatment for multiple sclerosis relapse.

Authors :
Choudhury NA
Castrodad-Molina RM
Hutton GJ
Cuascut FX
Source :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Feb; Vol. 58, pp. 103498. Date of Electronic Publication: 2022 Jan 04.
Publication Year :
2022

Abstract

First described more than 80 years ago, Elsberg Syndrome (ES) continues to be an under-recognized cause of cauda equina syndrome (CES). ES is an infectious disorder that presents with lower thoracic and/or lumbosacral myelitis in conjunction with CES, and most often occurs in the setting of herpes simplex virus 2 (HSV-2) reactivation (Savoldi et al., 2017; Eberhardt et al., 2004; Whalen et al., 2019). Comorbid neurologic diseases like multiple sclerosis (MS) can become a detrimental confounding factor leading to delayed diagnosis and management of ES due to pre-existing diagnostic bias. We present a case of relapsing-remitting MS (RRMS) complicated by ES, likely due to reactivation of a latent HSV infection following high immunosuppression for presumed refractory MS relapses.<br /> (Copyright © 2022 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
2211-0356
Volume :
58
Database :
MEDLINE
Journal :
Multiple sclerosis and related disorders
Publication Type :
Report
Accession number :
35007821
Full Text :
https://doi.org/10.1016/j.msard.2022.103498